Benzatropine Mesilate Tablets (Benztrop™)

Each Benztrop tablet contains 2 mg benzatropine mesilate, starch-pregelatinised maize, lactose, microcrystalline cellulose and magnesium stearate.

Indication:
For the treatment of all forms of parkinsonism and the treatment of extrapyramidal reactions (except tardive dyskinesia) due to neuroleptic drugs.

  • Strength: 2 mg tablets
  • Package: 60 tablet plastic bottle
  • Status: PBS
  • Phebra Code: TAB005
  • Pack Size: 12 bottles

Resources: